BMRN
BIOMARIN PHARMACEUTICAL INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
BIOMARIN PHARMACEUTICAL INC (BMRN) is held as common stock by 7 tracked hedge-fund managers, with a combined reported value of ~$1.51B; the largest are Dodge & Cox, Andreas Halvorsen, Izzy Englander. 3 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 4 trimmed, 1 closed. 16 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders73 also report options
Congress trades16
Price$59.46vs quarter-end+3.91%
Sectors0
This quarter's moves
Top holderDodge & CoxNew0
Added3
Trimmed / sold5
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $13.19M— of portfolio230,5002026 Q2
Value $2.87M— of portfolio50,1002026 Q2
Value $2.40M— of portfolio42,0002026 Q2
Value $526.4K— of portfolio9,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $13.19M | — | — |
| Ken GriffinPUT | $2.87M | — | — |
| Izzy EnglanderCALL | $2.40M | — | — |
| Paul Tudor JonesCALL | $526.4K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.